Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehisa Kawata

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Plos One|January 22, 2021
The effect of evocalcet on vagus nerve activity of the gastrointestinal tract in miniature pigsShin Tokunaga, Takehisa Kawata
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Experimental animal models of primary hyperparathyroidism]Yasuo Imanishi, Takehisa Kawata
Clinical Calcium|November 8, 2005
[The calcium receptor and magnesium metabolism]Takehisa Kawata, Nobuo Nagano
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 17, 2019
[Pharmacological and clinical profiles of a novel calcimimetic, evocalcet (ORKEDIA<sup>®</sup>)]Shin Tokunaga, Yuichi Endo, Takehisa Kawata
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 15, 2008
[Pharmacological and clinical profiles of calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients on dialysis (cinacalcet hydrochloride, REGPARA)]Nobuo Nagano, Takehisa Kawata, Michihito Wada
Expert Opinion on Drug Discovery|March 16, 2013
Animal models of hyperfunctioning parathyroid diseases for drug developmentYasuo Imanishi, Masaaki Inaba, Takehisa Kawata, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 22, 2009
Cinacalcet in hyperfunctioning parathyroid diseasesYasuo Imanishi, Masaaki Inaba, Takehisa Kawata, et al.
Expert Review of Endocrinology & Metabolism|June 20, 2020
Development of evocalcet for unmet needs among calcimimetic agentsNaoto Hamano, Yuichi Endo, Takehisa Kawata, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 6, 2007
Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseasesYasuo Imanishi, Keisuke Kobayashi, Takehisa Kawata, et al.
Plos One|February 17, 2022
Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidismTakashi Shigematsu, Shinji Asada, Yuichi Endo, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Plos One|January 22, 2021
The effect of evocalcet on vagus nerve activity of the gastrointestinal tract in miniature pigsShin Tokunaga, Takehisa Kawata
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Experimental animal models of primary hyperparathyroidism]Yasuo Imanishi, Takehisa Kawata
Clinical Calcium|November 8, 2005
[The calcium receptor and magnesium metabolism]Takehisa Kawata, Nobuo Nagano
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 17, 2019
[Pharmacological and clinical profiles of a novel calcimimetic, evocalcet (ORKEDIA<sup>®</sup>)]Shin Tokunaga, Yuichi Endo, Takehisa Kawata
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 15, 2008
[Pharmacological and clinical profiles of calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients on dialysis (cinacalcet hydrochloride, REGPARA)]Nobuo Nagano, Takehisa Kawata, Michihito Wada
Expert Opinion on Drug Discovery|March 16, 2013
Animal models of hyperfunctioning parathyroid diseases for drug developmentYasuo Imanishi, Masaaki Inaba, Takehisa Kawata, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 22, 2009
Cinacalcet in hyperfunctioning parathyroid diseasesYasuo Imanishi, Masaaki Inaba, Takehisa Kawata, et al.
Expert Review of Endocrinology & Metabolism|June 20, 2020
Development of evocalcet for unmet needs among calcimimetic agentsNaoto Hamano, Yuichi Endo, Takehisa Kawata, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 6, 2007
Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseasesYasuo Imanishi, Keisuke Kobayashi, Takehisa Kawata, et al.
Plos One|February 17, 2022
Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidismTakashi Shigematsu, Shinji Asada, Yuichi Endo, et al.
Pageof 4